160 related articles for article (PubMed ID: 34720069)
21. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Lopes CS
Ann Oncol; 2004 Oct; 15(10):1535-42. PubMed ID: 15367415
[TBL] [Abstract][Full Text] [Related]
22. A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.
Heimes AS; Schmidt M; Jäkel J; Almstedt K; Gebhard S; Weyer-Eiberich V; Elger T; Krajnak S; Brenner W; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2019 Jan; 299(1):239-246. PubMed ID: 30357498
[TBL] [Abstract][Full Text] [Related]
23. Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer.
Hakamy S; Assidi M; Jafri MA; Nedjadi T; Alkhatabi H; Al-Qahtani A; Al-Maghrabi J; Sait K; Al-Qahtani M; Buhmeida A; Chaudhary A
Libyan J Med; 2021 Dec; 16(1):1937866. PubMed ID: 34240668
[No Abstract] [Full Text] [Related]
24. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.
Trillsch F; Kuerti S; Eulenburg C; Burandt E; Woelber L; Prieske K; Eylmann K; Oliveira-Ferrer L; Milde-Langosch K; Mahner S
Br J Cancer; 2016 Jan; 114(2):213-20. PubMed ID: 26757261
[TBL] [Abstract][Full Text] [Related]
25. REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.
Jia W; Chang B; Sun L; Zhu H; Pang L; Tao L; Zou H; Du J; Dong Y; Qi Y; Jiang J; Liang W; Li F; Zhao X
Int J Clin Exp Pathol; 2014; 7(9):5940-9. PubMed ID: 25337238
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines.
Sicairos B; Alam S; Du Y
BMC Cancer; 2023 May; 23(1):441. PubMed ID: 37189027
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.
Miše BP; Telesmanić VD; Tomić S; Šundov D; Čapkun V; Vrdoljak E
Pathol Oncol Res; 2015 Apr; 21(2):347-56. PubMed ID: 25108408
[TBL] [Abstract][Full Text] [Related]
28. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
[TBL] [Abstract][Full Text] [Related]
29. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
Sun Y; Hu L; Zheng H; Bagnoli M; Guo Y; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Ji P; Chen K; Sood AK; Mezzanzanica D; Liu J; Sun B; Zhang W
J Pathol; 2015 Jan; 235(1):25-36. PubMed ID: 25230372
[TBL] [Abstract][Full Text] [Related]
30. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin expression in human epithelial ovarian cancer and normal ovary.
Sundfeldt K; Piontkewitz Y; Ivarsson K; Nilsson O; Hellberg P; Brännström M; Janson PO; Enerback S; Hedin L
Int J Cancer; 1997 Jun; 74(3):275-80. PubMed ID: 9221804
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
Diao B; Yang P
Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
[TBL] [Abstract][Full Text] [Related]
33. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
[TBL] [Abstract][Full Text] [Related]
34. Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
Zhu X; Yang H; Lang J; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():103-108. PubMed ID: 31242460
[TBL] [Abstract][Full Text] [Related]
35. Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression.
Li X; Yang J; Wang X; Li X; Liang J; Xing H
Eur J Gynaecol Oncol; 2016; 37(1):100-8. PubMed ID: 27048119
[TBL] [Abstract][Full Text] [Related]
36. Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.
Lin L; Nong W; Luo B; Ge Y; Zeng X; Li F; Fan R; Zhang Q; Xie X
Immun Inflamm Dis; 2021 Dec; 9(4):1759-1770. PubMed ID: 34528758
[TBL] [Abstract][Full Text] [Related]
37. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value of E-cadherin Expression in Breast Cancer.
Younis LK; El Sakka H; Haque I
Int J Health Sci (Qassim); 2007 Jan; 1(1):43-51. PubMed ID: 21475451
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
